U.S. Veterinary Cro And Cdmo Market Size & Outlook
U.S. veterinary cro and cdmo market, 2018-2030 (US$Ms)
Related Markets
U.S. veterinary cro and cdmo market highlights
- The U.S. veterinary cro and cdmo market generated a revenue of USD 1,741.1 millions in 2022 and is expected to reach USD 3,163.6 millions by 2030.
- The U.S. market is expected to grow at a CAGR of 7.8% from 2023 to 2030.
- In terms of segment, livestock animals was the largest revenue generating animal type in 2022.
- Companion Animals is the most lucrative animal type segment registering the fastest growth during the forecast period.
Veterinary cro and cdmo market data book summary
| Market revenue in 2022 | USD 1,741.1 millions |
| Market revenue in 2030 | USD 3,163.6 millions |
| Growth rate | 7.8% (CAGR from 2022 to 2030) |
| Largest segment | Livestock animals |
| Fastest growing segment | Companion Animals |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD millions |
| Market segmentation | Companion Animals, Livestock Animals |
| Key market players worldwide | Labcorp Holdings Inc, Charles River Laboratories International Inc, Hannover Rueck SE, Inotiv Inc, IDEXX Laboratories Inc, Zoetis Inc Class A, Swedencare AB, Clinvet, Oncovet Clinical Research, knoell, Vetspin |
Other key industry trends
- In terms of revenue, U.S. accounted for 30.0% of the global veterinary cro and cdmo market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. veterinary cro and cdmo market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 492.5 millions by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary CRO And CDMO Market Scope
Veterinary CRO And CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. veterinary cro and cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary cro and cdmo market will help companies and investors design strategic landscapes.
Livestock animals was the largest segment with a revenue share of 59.68% in 2022. Horizon Databook has segmented the U.S. veterinary cro and cdmo market based on companion animals, livestock animals covering the revenue growth of each sub-segment from 2018 to 2030.
Major players in the animal health industry often prefer contract outsourcing over in-house manufacturing due to its numerous advantages. Zoetis, one of the biggest competitors in the veterinary sector, exemplifies this trend with its reliance on 132 third-party contract manufacturing organizations, despite having only 29 internal manufacturing facilities.
Hence, animal health medicine or device producers only outsource crucial production steps to knowledgeable CROs and CDMOs due to the complicated manufacturing processes of some veterinary products. Companies can lower financial risk by outsourcing activities and promoting greater advancements and research.
Reasons to subscribe to U.S. veterinary cro and cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. veterinary cro and cdmo market databook
-
Our clientele includes a mix of veterinary cro and cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary cro and cdmo market , including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary cro and cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. veterinary cro and cdmo market size, by animal type, 2018-2030 (US$Ms)
U.S. Veterinary CRO And CDMO Market Outlook Share, 2022 & 2030 (US$Ms)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
